Advertisement

Topics

Pricing Deregulation: 340B Pharmacy Policy, Medicaid Payment Rules May Be Withdrawn

13:17 EDT 22 Jun 2017 | SCRIP

Trump administration's drug pricing action plan considers withdrawing guidance and whole or parts of rules that biopharma has opposed.

      

Related Stories

 

Original Article: Pricing Deregulation: 340B Pharmacy Policy, Medicaid Payment Rules May Be Withdrawn

NEXT ARTICLE

More From BioPortfolio on "Pricing Deregulation: 340B Pharmacy Policy, Medicaid Payment Rules May Be Withdrawn"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...